Seres Therapeutics Inc.

0.68
0.00 (0.56%)
At close: Apr 02, 2025, 3:59 PM
0.67
-1.73%
After-hours: Apr 02, 2025, 07:51 PM EDT

Seres Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for MCRB stock have an median target of 1.25, with a low estimate of 0.75 and a high estimate of 10. The median target predicts an increase of 83.82% from the current stock price of 0.68.

Target Low Average Median High
Price $0.75 $4 $1.25 $10
Change 10.29% 488.24% 83.82% 1370.59%

Latest Analyst Insight Report

Chardan Capital has reaffirmed a Buy rating for Se... Unlock content with Pro Subscription

Updated Mar 20, 2025

Rating Jun 24Aug 24Sep 24Oct 24Nov 24Mar 25
Strong Buy 000000
Buy 121021
Hold 100000
Sell 000101
Strong Sell 000000
Total 2 2 1 1 2 2

Financial Forecast this Year

Revenue This Year
33.08M
from 0
Increased by -%
Revenue Next Year
15M
from 33.08M
Increased by -54.7%
EPS This Year
-0.16
from 0
Increased by -%
EPS Next Year
-0.24
from -0.16
Increased by -50%